financetom
Business
financetom
/
Business
/
Volvo Trucks to launch electric truck with 600 km range
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Volvo Trucks to launch electric truck with 600 km range
Sep 3, 2024 12:40 AM

(Reuters) - Sweden's Volvo will launch a long-range variant of its FH Electric truck, capable of covering up to 600 km (373 miles) on a single charge, its truckmaking arm said on Tuesday.

The new model, expected to hit the market in the second half of 2025, caters to customers requiring longer hauls by maximizing battery space while improving the truck's software.

Volvo Trucks, a global leader in electric trucks, said it would use an electronic axle technology that combines motor, gearbox and axle into one unit, increasing battery capacity.

Volvo Trucks' head of product management and quality Jan Hjelmgren told Reuters the company was accelerating its green investments, but further action from politicians would be crucial for broader adoption of zero-emission vehicles.

Heavy truck market in Europe is expected to slow down this year after three years of high demand, which last year resulted in the highest delivery levels in more than 15 years as supply chain disruptions eased.

Additionally, battery-electric vehicles are losing market share in Europe due to inconsistent green policies and lack of sufficient political subsidies.

As of last year, electric trucks were still significantly more expensive than their diesel counterparts, with prices ranging from 250,000 euros to 400,000 euros ($276,525 to $442,440).

Last month, Volvo said it had chosen Monterrey as the location for its new $700 million North American truck plant, set to start operations in 2026.

Hjelmgren said the Monterrey factory would play a crucial role in supporting Volvo Trucks' North American growth strategy by providing the industrial capacity needed to meet increasing demand. 

($1 = 0.9041 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved